2009
DOI: 10.1016/j.biomaterials.2009.01.010
|View full text |Cite
|
Sign up to set email alerts
|

Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

20
597
1
4

Year Published

2010
2010
2014
2014

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 639 publications
(622 citation statements)
references
References 29 publications
20
597
1
4
Order By: Relevance
“…Importantly, the vast amount of pH-responsive systems are used to enable controlled release of hydrogel payload rather than used to persue a switch in material properties thereby controlling catheter-guided injection. [ 22 ] Synthetic supramolecular hydrogelators [23][24][25][26][27][28][29] that are held together by directed, noncovalent interactions are proposed to allow for full control of their sol-gel switching behavior under mild conditions using the dynamic nature of the supramolecular interactions. When exploited to the fullest, supramolecular switchable hydrogels systems might be the solution for future clinical catheter-delivery therapies.…”
Section: Introductionmentioning
confidence: 99%
“…Importantly, the vast amount of pH-responsive systems are used to enable controlled release of hydrogel payload rather than used to persue a switch in material properties thereby controlling catheter-guided injection. [ 22 ] Synthetic supramolecular hydrogelators [23][24][25][26][27][28][29] that are held together by directed, noncovalent interactions are proposed to allow for full control of their sol-gel switching behavior under mild conditions using the dynamic nature of the supramolecular interactions. When exploited to the fullest, supramolecular switchable hydrogels systems might be the solution for future clinical catheter-delivery therapies.…”
Section: Introductionmentioning
confidence: 99%
“…From a more-applied perspective, interest in peptide-and protein-based fibrous biomaterials has increased recently because these materials have potential applications in biotechnology and synthetic biology-for example, as scaffolds for 3D cell culture, tissue engineering, and templating the assembly of functional inorganic materials (10)(11)(12)(13). Although natural proteins can and are being used in these areas, much simpler or stripped-down systems are preferable because they reduce complexity, and potentially allow better understanding and control over the folding and assembly processes leading to fiber formation.…”
mentioning
confidence: 99%
“…However, no design process is complete until the structures of the components and their assemblies have been determined to high resolution to afford molecular and, ideally, atomistic descriptions. Although in silico models for several of the above systems have been presented (11,15,16) and structures for amyloid-like assemblies formed from small peptides are being resolved (17,18), there is currently no high-resolution experimental structure for a fibrous biomaterial of de novo design.…”
mentioning
confidence: 99%
“…More recently, next generation systems are being modified to introduce functionality, potentially at the expense of homogeneous assembly, as depicted in Fig. 1 [38,39]. This approach generally attempts to mimic the ECM to provide structural and biochemical support to control and augment tissue repair.…”
Section: Functionalisation Of Peptide Materialsmentioning
confidence: 99%
“…For example, the bioactive sequence fmoc-RGD selfassembles into a well ordered p-b nanoscale assembly and a clear hydrogel [44]. However, doping of fmoc-RGD into a system predominantly consisting of fmoc-FF results in the disruption of the ordering of the system but an increase in the biofunctionality [38]. The presentation of RGD has also been observed to be a function of the aromatic sidechains flanking the epitope, where fmoc-RDGF has a greater bioavailability than fmoc-FRGD, possibly through increased rigidity provided by the aromatic residue at the C terminal [45].…”
Section: Functionalisation Of Peptide Materialsmentioning
confidence: 99%